查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190615

一次性医疗器械传感器市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Disposable Medical Devices Sensors Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022 年至 2027 年的预测期内，一次性医疗设备传感器市场预计将以 10.8% 的复合年增长率增长。

COVID-19 的爆发增加了全球对一次性医疗设备传感器的需求。 这主要是由于 COVID-19 病毒的高毒力导致医疗机构加强了感染控制措施。 公众对更快获得测试结果的简便方法的认识不断提高，这也促进了需求的增长。 为了方便和安全，消费者越来越多地选择远程医疗机构。 世界各地的研究人员都在争先恐后地开发新方法，使用准确高效的生物传感器在 SARS-CoV-2 大流行期间进行早期检测。 例如，2020 年 4 月，加拿大卫生部将 Dexcom G6 连续血糖监测传感器系统整合到医疗设备中，以便在应对 COVID-19 大流行的情况下扩展使用。 Dexcom G6传感器的加拿大医疗器械许可证规定，它只能佩戴在一般成年人的腹部（肚皮）上。 因此，预计 COVID-19 流行期间对一次性医疗器械的需求增加将对市场产生积极影响。

一次性医疗设备传感器市场受医疗成本上升、政府对研发活动的资助以及新兴经济体对传感器技术的接受等因素推动。 例如，根据欧盟统计局 2021 年 12 月发布的数据，德国和法国在 2019 年的当前医疗保健支出占 GDP 的比重最高。 德国目前的医疗支出水平在 2019 年达到 4030 亿欧元，仍然是欧盟 (EU) 成员国中最高的。 德国和法国目前的医疗保健支出分别占国内生产总值 (GDP) 的 11.7% 和 11.1%，高于任何其他欧盟成员国。 其次是瑞典（10.9%）、比利时（10.7%）、奥地利（10.4%）、荷兰（10.2%）和丹麦（10.0%），其余欧盟成员国均未达到两位数百分比。 因此，不断上涨的医疗保健成本支持了预测期内的市场增长。

根据发表在 IEE 期刊上的题为“Biosensors and Chemical Sensors for Healthcare Monitoring, A Review”的论文，欧盟成员国的医疗支出正在上升，支撑了预测期内的市场增长。 根据 2022 年 3 月在 IEEJ 电气和电子工程彙刊上发表的“评论”，将生物传感器和设备用于医疗诊断和预防目的至关重要。 在发达国家，需要可以在日常生活中使用的医疗设备（特别是用于检测、诊断和传感），以遏制与生活方式相关的疾病的增加和严重程度。 可穿戴生化设备是重要的个人设备，将发挥主导作用。 诊断设备现在在医学上用于疾病预防和健康管理。 也应该可以抑制医疗和护理费用的上涨。 因此，生物传感器在一次性医疗设备中的上述优势有望在预测期内推动市场增长。

因此，考虑到上述因素，一次性医疗设备传感器市场有望在预测期内得到推动。 然而，严格的监管环境和对新诊断技术缺乏认识阻碍了市场增长。

主要市场趋势

患者监护预计在预测期内快速增长

患者监护是增长最快的市场之一，一次性传感器广泛用于患者监护。 在发展中国家的城市和农村地区，对家庭患者监测的需求不断增长。 这种不断增长的需求使公司能够大量使用医疗设备传感器来监测患者。

远程患者监控允许医生和医院在传统医生办公室之外监控患者，该技术可以在患者和医生之间提供 24/7 数据。 根据 2021 年版的医疗保险和医疗补助服务中心，患者监护仪每年都会帮助数十万高危患者避免再次入院并在家中过上更健康的生活。 使用远程监控的客户报告说再入院率降低了 76%，平均患者满意度为 89%，并节省了大约 3.7 亿美元的总医疗费用。

不仅在日本，在世界各地也有许多公司在处理用于患者监护的一次性传感器。 提供这些传感器的知名公司包括 Smiths Medical 和 Mediaid。 此外，2020 年 5 月，持续健康监测和临床情报公司 BioIntelliSense, Inc. 通过推出 BioButton 设备，推进了其医疗级生物传感器产品组合和数据即服务 (DaaS) 平台。 生物按钮是一种硬币大小的一次性医疗设备，可以连续测量体温和其他生命体征 90 天。 Biotellisense 是一种医疗级数据服务，它使用专有的生物传感器技术和高级分析来实现有害趋势的早期检测，而成本仅为温度测量和传统远程患者监测 (RPM) 系统的一小部分。

这表明传感器在医疗设备中的使用有所增加，这将对预测期内研究的市场产生直接的积极影响。

北美在市场上占主导地位，预计在预测期内也会如此。

随着创新传感器开发技术的进步、基于传感器的设备在该地区的广泛采用以及不断上升的医疗保健成本成为该地区市场增长的主要驱动力，预计北美将主导该市场。. 由于所研究的市场中存在主要参与者，美国拥有最大的市场份额。

根据医疗保险和医疗补助服务中心 2021 年 12 月的数据，2019-28 年全国医疗保健支出预计将以年均 5.4% 的速度增长，到 2028 年将达到 6.2 万亿美元。 预计 2019-28 年全国卫生支出年均增长速度将比国内生产总值快 1.1 个百分点，因此卫生支出在经济中的份额预计将从 2018 年的 17.7% 上升到 2028 年的 19.7%。

此外，风险投资公司增加了对新型一次性医疗设备传感器开发的投资。 例如，2022 年 5 月，Nemaura Medical, Inc. 是一家专注于将日常一次性可穿戴葡萄糖传感器商业化并支持个性化数字教练计划的医疗技术公司，宣布了一项没有认股权证或可转换元素的清洁债务融资。据报导，它已获得 500 万美元的非稀释资金。

此外，主要市场参与者增加产品发布将进一步推动预测期内的市场增长。 例如，2020 年 7 月，生物传感器技术先驱 ivWatch, LLC 的新型 SmartTouchTM 一次性传感器获得了美国食品药品监督管理局 (FDA) 的许可，用于早期检测外周静脉浸润和外渗事件。 此次 FDA 批准扩大了 ivWatch 传感器产品组合，为医院、输液中心和其他医疗机构提供互补的传感器解决方案，有助于提高患者安全并降低与输液治疗相关的风险。

因此，上述所有因素都有望在预测期内推动市场增长。

竞争格局

这个市场的竞争很低，大多数本地公司都在内部竞争。 然而，大部分市场份额被全球公司占据。 在印度和南非等新兴国家，当地公司正以较低的产品价格展开激烈竞争。 相信在不久的将来，这类中小企业将获得很大的份额。 主要公司包括 Honeywell International, Inc.、Medtronic plc、Koninklijke Philips N.V.、Sensirion AG 和 Smiths Medical。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章 调查手法

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 与医疗保健相关的支出增加
    • 鼓励风险投资公司投资开发新型一次性医疗设备传感器
    • 传感器技术的进步和接受度的快速提高
  • 市场製约因素
    • 严格的监管场景
    • 缺乏对新诊断技术的认识
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按产品分类
    • 生物传感器
    • 图像传感器
    • 加速度计
    • 温度传感器
    • 其他
  • 通过申请
    • 病人监护
    • 诊断
    • 治疗药物
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • NXP Semiconductors（Freescale Semiconductor, Inc.）
    • GE Healthcare
    • Gentag Inc.
    • Honeywell International, Inc.
    • Medtronic plc
    • Koninklijke Philips N.V.
    • Sensirion AG
    • Medical Sensors India Pvt. Ltd
    • Shenzhen Med-Link Electronics Tech Co., Ltd.
    • Starboard Medical, Inc.
    • Smiths Medical
    • Nuova GmbH

第7章 市场机会与今后动向

简介目录
Product Code: 49953

Disposable Medical Devices Sensors Market is poised to grow at a CAGR of 10.8% during the forecast period, 2022-2027.

The global demand for disposable medical device sensors has increased as a result of the COVID-19 outbreak. This is primarily due to increased infection control measures in healthcare settings as a result of the COVID-19 virus's high virulence. People's growing awareness of simple and convenient ways to obtain faster test results also contributes to the rising demand. Consumers are increasingly choosing remote healthcare facilities for the convenience and security of their own homes. Researchers around the world have been rushing to develop accurate and efficient novel biosensor-based approaches for the early detection of SARS-CoV-2 during the current pandemic. For Instance, in April 2020, Health Canada has included the Dexcom G6 Continuous Glucose Monitoring Sensor System in medical devices for expanded use in relation to the COVID-19 pandemic. The Dexcom G6 Sensor's Canadian Medical Device Licence specifies that it be worn on the abdomen in the general adult population (belly). Thus, during the COVID-19 the demand for the disposable medical devices increased thereby expected to show positive impact on the market.

The Disposable Medical Devices Sensors market is being driven by factors such as increasing healthcare expenditure, government provisions for R&D activities, and acceptance of the sensor technology in the developing economies. For instance, according to Eurostat data published in December 2021, Germany and France had the highest current healthcare expenditure relative to GDP in 2019. The level of current healthcare expenditure in Germany was EUR 403 billion in 2019 and remains at the highest level among the European Union (EU) Member States. Current healthcare expenditure in Germany and France was equivalent to 11.7 % and 11.1 %, respectively, of gross domestic product (GDP), more than in any other EU Member State. The next highest ratios were in Sweden (10.9 %), Belgium (10.7 %), Austria (10.4 %), the Netherlands (10.2 %) and Denmark (10.0 %); none of the remaining EU Member States recorded double-digit ratios. Thus, increasing healthcare expenditure supports the market growth over the forecast period.

According to the study titled "Biosensors and Chemical Sensors for Healthcare Monitoring: A Review" published in the IEEJ Transactions on Electrical and Electronic Engineering in March 2022, It has been a top priority to use biosensors and equipment for medical diagnostic and preventive purposes. In order to control the rise in lifestyle-related diseases and their severity, developed countries need medical devices that can be used in daily life (especially for testing, diagnosis, and sensing). Wearable biological and chemical devices are significant personal devices that will be a key player in this process. Diagnostic devices are currently used in medicine for disease prevention and health management. They should also keep the costs of medical and nursing care from rising. Thus, due to the above benefits of the disposable medical devices biosensor anticipated to drive the growth of the market over the forecast period.

Thus, given the aforementioned factors, the disposable medical devices sensor market is anticipated to propel over the forecast period. However, stringent regulatory scenario and lack of awareness of new diagnostics technologies restraint the market growth.

Key Market Trends

Patient Monitoring is Expected to Show Rapid Growth Over the Forecast Period

Patient monitoring is one of the rapidly growing markets and disposable sensors are widely being used for patient monitoring. In the rural as well as urban areas of developing countries, there is a growing demand for in-home patient monitoring. This rising demand is allowing the companies to utilize medical device sensors largely for patient monitoring.

Remote patient monitoring allows physicians and hospitals to monitor patients outside of the conventional clinic setting, where the technology can provide 24/7 data between patients and physicians. According to the center of Medicare and Medicaid Services 2021, every year, patient monitors help hundreds of thousands of high-risk patients avoid being readmitted to the hospital and make the most of their healthy days at home. Clients who use remote monitoring report a 76% reduction in readmission rates, an average of 89 % patient satisfaction, and a total medical cost savings of nearly USD 370 million.​

There is a large number of local as well as global companies that are into the disposable sensors for patient monitoring. Some of the well-known players providing these sensors include Smiths Medical, Mediaid, Inc., etc. Additionally, in May 2020, BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, reported the advancement of its medical-grade biosensor product portfolio and Data-as-a-Service (DaaS) platform with the introduction of the BioButton device. The BioButton is a coin-sized, disposable medical device that measures continuous temperature and other vital signs for a remarkable 90-days. BioIntelliSense offers medical-grade data services that allow for early detection of adverse trends through its proprietary biosensor technology and advanced analytics at a fraction of the cost of spot temperature measurements or traditional Remote Patient Monitoring (RPM) systems.

This indicates the rising use of medical device sensors which will directly affect the market studied in a positive manner over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the market and the major factors attributed to the growth of the market in the region are a technological advancement in innovative sensors development and the high adoption rate of sensors-based devices in the region, rising healthcare spending. United States holds the largest market share due to the presence of key players in the market studied.

According to the Centers for Medicare & Medicaid Services in December 2021, the National health spending is projected to grow at an average annual rate of 5.4% for 2019-28 and to reach USD 6.2 trillion by 2028. As national health expenditures are projected to grow 1.1 percentage points faster than gross domestic product per year on average over 2019-28, the health share of the economy is projected to rise from 17.7% in 2018 to 19.7% in 2028.

Moreover, enhanced investments by venture capital firms to develop novel disposable medical device sensors. For instance, in May 2022, Nemaura Medical, Inc. a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, reported that it has secured USD 5 million in non-dilutive funding though a clean debt facility with no warrants or convertible elements.

In addition, increasing product launches by the key market player further expand the market growth over the projecting period. For instance, in July 2020, ivWatch, LLC, a pioneer in biosensor technology, has received Food and Drug Administration (FDA) clearance for its new SmartTouchTM disposable sensor for the early detection of peripheral IV infiltration and extravasation events. This new FDA clearance expands the ivWatch sensor portfolio to provide hospitals, infusion centers, and other healthcare facilities with complementary sensor solutions to help improve patient safety and reduce the risks associated with IV therapy.

Thus, all aforementioned factors anticipated to boost the market growth over the forecast period.

Competitive Landscape

The market studied is moderately competitive and most of the local companies are having internal competition among themselves. The larget market share, however, is gained by global companies. In developing countries such as India, South Africa, etc., the local companies are posing intense competition due to the low prices of the products. In the near future, such small to mid-sized companies are believed to gain a substantial share of the market. Some of the key players are Honeywell International, Inc., Medtronic plc, Koninklijke Philips N.V., Sensirion AG, Smiths Medical

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Healthcare Expenditure
    • 4.2.2 Enhanced Investments by Venture Capital Firms to Develop Novel Disposable Medical Devices Sensors
    • 4.2.3 Rapid Increase in Advancement an Acceptance of Sensor Technology
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Scenario
    • 4.3.2 Lack of Awareness in New Diagnostics Technologies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Biosensor
    • 5.1.2 Image Sensor
    • 5.1.3 Accelerometer
    • 5.1.4 Temperature Sensors
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Patient Monitoring
    • 5.2.2 Diagnostics
    • 5.2.3 Therapeutics
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 NXP Semiconductors (Freescale Semiconductor, Inc.)
    • 6.1.2 GE Healthcare
    • 6.1.3 Gentag Inc.
    • 6.1.4 Honeywell International, Inc.
    • 6.1.5 Medtronic plc
    • 6.1.6 Koninklijke Philips N.V.
    • 6.1.7 Sensirion AG
    • 6.1.8 Medical Sensors India Pvt. Ltd
    • 6.1.9 Shenzhen Med-Link Electronics Tech Co., Ltd.
    • 6.1.10 Starboard Medical, Inc.
    • 6.1.11 Smiths Medical
    • 6.1.12 Nuova GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS